Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-blinded Study of UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.

NCT05043662 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT05043662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05043662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-blinded Study of UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2021
Completion date
December 30, 2022
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytology, diagnoses disease, image, ureter cancer, urothelial carcinoma